Metabolomics study of hepatocellular carcinoma: Discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry

Journal of Proteome Research

Volumn 13, Issue 7, 2014, Pages 3420-3431

  Zeng, Jun ^a   Yin, Peiyuan ^a   Tan, Yexiong ^b   Dong, Liwei ^b   Hu, Chunxiu ^a   Huang, Qiang ^a   Lu, Xin ^a   Wang, Hongyang ^b   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

biomarkers; capillary electrophoresis; HCC; hepatocellular carcinoma; mass spectrometry; metabolomics; serum

Indexed keywords

2 HYDROXYBUTYRIC ACID; ALPHA FETOPROTEIN; ARGININE; GLUTAMINE; HEPATITIS B SURFACE ANTIGEN; HYDROXYBUTYRIC ACID; TRYPTOPHAN; TUMOR MARKER; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLOMICS; PATTERN RECOGNITION; PRECANCER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TIME OF FLIGHT MASS SPECTROMETRY; ADULT; BLOOD; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; FEMALE; ISOLATION AND PURIFICATION; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; MIDDLE AGED;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; METABOLOMICS; MIDDLE AGED; ROC CURVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84903731487     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500390y     Document Type: Article

References (40)

1. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global Cancer Statistics, 2002 Ca-Cancer J. Clin. 2005, 55 (2) 74-108
2. Chen, J. G.; Zhang, S. W. Liver Cancer Epidemic in China: Past, Present and Future Semin. Cancer Biol. 2011, 21 (1) 59-69
3. Sakamoto, M. Early HCC: Diagnosis and Molecular Markers J. Gastroenterol. 2009, 44, 108-111
4. Ryder, S. D. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (HCC) in Adults Gut 2003, 52, III1-III8
5. Parikh, S.; Hyman, D. Hepatocellular Cancer: A Guide for the Internist Am. J. Med. 2007, 120 (3) 194-202
6. Colli, A.; Fraquelli, M.; Casazza, G.; Massironi, S.; Colucci, A.; Conte, D.; Duca, P. Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review Am. J. Gastroenterol. 2006, 101 (3) 513-523
7. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J. D.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X. H.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic Profiles Delineate Potential Role for Sarcosine in Prostate Cancer Progression Nature 2009, 457 (7231) 910-914
8. Hirayama, A.; Kami, K.; Sugimoto, M.; Sugawara, M.; Toki, N.; Onozuka, H.; Kinoshita, T.; Saito, N.; Ochiai, A.; Tomita, M.; Esumi, H.; Soga, T. Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry Cancer Res. 2009, 69 (11) 4918-4925
9. Jain, M.; Nilsson, R.; Sharma, S.; Madhusudhan, N.; Kitami, T.; Souza, A. L.; Kafri, R.; Kirschner, M. W.; Clish, C. B.; Mootha, V. K. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation Science 2012, 336 (6084) 1040-1044
10. Soga, T.; Sugimoto, M.; Honma, M.; Mori, M.; Igarashi, K.; Kashikura, K.; Ikeda, S.; Hirayama, A.; Yamamoto, T.; Yoshida, H.; Otsuka, M.; Tsuji, S.; Yatomi, Y.; Sakuragawa, T.; Watanabe, H.; Nihei, K.; Saito, T.; Kawata, S.; Suzuki, H.; Tomita, M.; Suematsu, M. Serum Metabolomics Reveals Gamma-Glutamyl Dipeptides As Biomarkers for Discrimination among Different Forms of Liver Disease J. Hepatol. 2011, 55 (4) 896-905
11. Brindle, J. T.; Antti, H.; Holmes, E.; Tranter, G.; Nicholson, J. K.; Bethell, H. W. L.; Clarke, S.; Schofield, P. M.; McKilligin, E.; Mosedale, D. E.; Grainger, D. J. Rapid and Noninvasive Diagnosis of the Presence and Severity of Coronary Heart Disease Using H-1-NMR-Based Metabonomics Nat. Med. 2002, 8 (12) 1439-1444
12. Yang, J.; Chen, T.; Sun, L.; Zhao, Z.; Qi, X.; Zhou, K.; Cao, Y.; Wang, X.; Qiu, Y.; Su, M.; Zhao, A.; Wang, P.; Yang, P.; Wu, J.; Feng, G.; He, L.; Jia, W.; Wan, C. Potential Metabolite Markers of Schizophrenia Mol. Psychiatry 2013, 18 (1) 67-78
13. Tan, Y. X.; Yin, P. Y.; Tang, L.; Xing, W. B.; Huang, Q.; Cao, D.; Zhao, X. J.; Wang, W. Z.; Lu, X.; Xu, Z. L.; Wang, H. Y.; Xu, G. W. Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma Diagnosis Mol. Cell. Proteomics 2012, 11 (2) 12
14. Wang, B. H.; Chen, D. Y.; Chen, Y.; Hu, Z. H.; Cao, M.; Xie, Q.; Chen, Y. F.; Xu, J. L.; Zheng, S. S.; Li, L. J. Metabonomic Profiles Discriminate Hepatocellular Carcinoma from Liver Cirrhosis by Ultraperformance Liquid Chromatography-Mass Spectrometry J. Proteome Res. 2012, 11 (2) 1217-1227
15. Chen, T. L.; Xie, G. X.; Wang, X. Y.; Fan, J.; Qiu, Y. P.; Zheng, X. J.; Qi, X.; Cao, Y.; Su, M. M.; Wang, X. Y.; Xu, L. X.; Yen, Y.; Liu, P.; Jia, W. Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma Mol. Cell. Proteomics 2011, 10 (7) 13
16. Ramautar, R.; Mayboroda, O. A.; Somsen, G. W.; de Jong, G. J. CE-MS for Metabolomics: Developments and Applications in the Period 2008-2010 Electrophoresis 2011, 32 (1) 52-65
17. Possemato, R.; Marks, K. M.; Shaul, Y. D.; Pacold, M. E.; Kim, D.; Birsoy, K.; Sethumadhavan, S.; Woo, H.-K.; Jang, H. G.; Jha, A. K.; Chen, W. W.; Barrett, F. G.; Stransky, N.; Tsun, Z.-Y.; Cowley, G. S.; Barretina, J.; Kalaany, N. Y.; Hsu, P. P.; Ottina, K.; Chan, A. M.; Yuan, B.; Garraway, L. A.; Root, D. E.; Mino-Kenudson, M.; Brachtel, E. F.; Driggers, E. M.; Sabatini, D. M. Functional Genomics Reveal That the Serine Synthesis Pathway Is Essential in Breast Cancer Nature 2011, 476 (7360) 346-350
18. Mullen, A. R.; Wheaton, W. W.; Jin, E. S.; Chen, P. H.; Sullivan, L. B.; Cheng, T.; Yang, Y.; Linehan, W. M.; Chandel, N. S.; DeBerardinis, R. J. Reductive Carboxylation Supports Growth in Tumour Cells with Defective Mitochondria Nature 2012, 481 (7381) 385-388
19. Opitz, C. A.; Litzenburger, U. M.; Sahm, F.; Ott, M.; Tritschler, I.; Trump, S.; Schumacher, T.; Jestaedt, L.; Schrenk, D.; Weller, M.; Jugold, M.; Guillemin, G. J.; Miller, C. L.; Lutz, C.; Radlwimmer, B.; Lehmann, I.; von Deimling, A.; Wick, W.; Platten, M. An Endogenous Tumour-Promoting Ligand of the Human Aryl Hydrocarbon Receptor Nature 2011, 478 (7368) 197-203
20. Cheng, P. N. M.; Lam, T. L.; Lam, W. M.; Tsui, S. M.; Cheng, A. W. M.; Lo, W. H.; Leung, Y. C. Pegylated Recombinant Human Arginase (rhArg-peg(5,000mw)) Inhibits the in Vitro and in Vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion Cancer Res. 2007, 67 (1) 309-317
21. Yin, P.; Peter, A.; Franken, H.; Zhao, X.; Neukamm, S. S.; Rosenbaum, L.; Lucio, M.; Zell, A.; Haring, H. U.; Xu, G.; Lehmann, R. Preanalytical Aspects and Sample Quality Assessment in Metabolomics Studies of Human Blood Clin. Chem. 2013, 59, 833-845
22. Gika, H. G.; Theodoridis, G. A.; Wingate, J. E.; Wilson, I. D. Within-Day Reproducibility of an HPLC-MS-Based Method for Metabonomic Analysis: Application to Human Urine J. Proteome Res. 2007, 6 (8) 3291-3303
23. Bijlsma, S.; Bobeldijk, L.; Verheij, E. R.; Ramaker, R.; Kochhar, S.; Macdonald, I. A.; van Ommen, B.; Smilde, A. K. Large-Scale Human Metabolomics Studies: A Strategy for Data (Pre-) Processing and Validation Anal. Chem. 2006, 78 (2) 567-574
24. Huang, Z. Z.; Lin, L.; Gao, Y.; Chen, Y. J.; Yan, X. M.; Xing, J. C.; Hang, W. Bladder Cancer Determination Via Two Urinary Metabolites: A Biomarker Pattern Approach Mol. Cell. Proteomics 2011, 10 (10) 10
25. Nuamah, I. F.; Qu, Y.; Amini, S. B. A SAS Macro for Stepwise Correlated Binary Regression Comput. Methods Programs Biomed. 1996, 49 (3) 199-210
26. Huang, Q.; Tan, Y. X.; Yin, P. Y.; Ye, G. Z.; Gao, P.; Lu, X.; Wang, H. Y.; Xu, G. W. Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics Cancer Res. 2013, 73 (16) 4992-5002
27. Denoix, P. Enquete Permanent Dans les Centres Anticancereaux Bull. Inst. Natl. Hyg. (Fr.) 1946, 1, 70-75
28. Warburg, O. Origin of Cancer Cells Science 1956, 123 (3191) 309-314
29. Medina, M. A.; Sanchezjimenez, F.; Marquez, J.; Quesada, A. R.; Decastro, I. N. Relevance of Glutamine-Metabolism to Tumor-Cell Growth Mol. Cell. Biochem. 1992, 113 (1) 1-15
30. DeBerardinis, R. J.; Mancuso, A.; Daikhin, E.; Nissim, I.; Yudkoff, M.; Wehrli, S.; Thompson, C. B. Beyond Aerobic Glycolysis: Transformed Cells Can Engage in Glutamine Metabolism That Exceeds the Requirement for Protein and Nucleotide Synthesis Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (49) 19345-19350
31. Cheng, P. N. M.; Leung, Y. C.; Lo, W. H.; Tsui, S. M.; Lam, K. C. Remission of Hepatocellular Carcinoma with Arginine Depletion Induced by Systemic Release of Endogenous Hepatic Arginase Due to Transhepatic Arterial Embolisation, Augmented by High-Dose Insulin: Arginase As a Potential Drug Candidate for Hepatocellular Carcinoma Cancer Lett. 2005, 224 (1) 67-80
32. Wheatley, D. N. Arginine Deprivation and Metabolomics: Important Aspects of Intermediary Metabolism in Relation to the Differential Sensitivity of Normal and Tumour Cells Semin. Cancer Biol. 2005, 15 (4) 247-253
33. Wheatley, D. N.; Campbell, E. Arginine Catabolism, Liver Extracts and Cancer Pathol. Oncol. Res. 2002, 8 (1) 18-25
34. Morris, S. M. Regulation of Enzymes of the Urea Cycle and Arginine Metabolism Ann. Rev. Nutr. 2002, 22, 87-105
35. Wheatley, D. N.; Campbell, E. Arginine Deprivation, Growth Inhibition and Tumour Cell Death: 3. Deficient Utilisation of Citrulline by Malignant Cells Br. J. Cancer 2003, 89 (3) 573-576
36. Platten, M.; Wick, W.; Van den Eynde, B. J. Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion Cancer Res. 2012, 72 (21) 5435-5440
37. Pilotte, L.; Larrieu, P.; Stroobant, V.; Colau, D.; Dolusic, E.; Frederick, R.; De Plaen, E.; Uyttenhove, C.; Wouters, J.; Masereel, B.; Van den Eynde, B. J. Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (7) 2497-2502
38. Munn, D. H.; Sharma, M. D.; Baban, B.; Harding, H. P.; Zhang, Y. H.; Ron, D.; Mellor, A. L. GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase Immunity 2005, 22 (5) 633-642
39. Prendergast, G. C.; Chang, M. Y.; Mandik-Nayak, L.; Metz, R.; Muller, A. J. Indoleamine 2,3-Dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases Curr. Med. Chem. 2011, 18 (15) 2257-2262
40. Gall, W. E.; Beebe, K.; Lawton, K. A.; Adam, K. P.; Mitchell, M. W.; Nakhle, P. J.; Ryals, J. A.; Milburn, M. V.; Nannipieri, M.; Camastra, S.; Natali, A.; Ferrannini, E.; Grp, R. S. alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population PLoS One 2010, 5 (5) 11